Natural-gas producer BKV and drug-developer BioAge queue up …
WEB1 day ago · Natural-gas producer BKV Inc.’s initial public offering priced below its estimated range at $18 a share, while BioAge Labs Inc., an obesity-drug developer, priced in the middle of its range in a ...
BioAge, BKV shares end their first trading day flat after earlier gains
WEB1 day ago · Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell and natural-gas producer BKV Corp. ended flat Thursday, the day the two initial public offerings debuted. At the ...
BioAge posts double-digit percentage jump after IPO; natural-gas ...
WEB1 day ago · BioAge (BIOA) shares opened at $22.50 and recently changed hands at $21.96, above their $18 IPO price. BKV's stock (BKV) opened at $18.55 a share, above its own $18 IPO price, and was trading at ...
BKV Corporation Announces Closing of Initial Public Offering
WEB6 hours ago · September 27, 2024 4:15 pm EDT Download as PDF. DENVER-- (BUSINESS WIRE)-- BKV Corporation (“BKV”) (NYSE: BKV) today announced the closing of its initial public offering of 15,000,000 shares of its common stock at $18.00 per share. The underwriters have a 30-day option to purchase an additional 2,250,000 shares from BKV at …
Weight-loss drug developer BioAge Labs aims to raise $198M …
WEBWeight-loss drug developer BioAge Labs (BIOA) on Wednesday announced the pricing of its upsized initial public offering of 11,000,000 shares of its common stock at a public offering price of $18. ...
BioAge, BKV shares end their first trading day flat after earlier gains
WEB2 days ago · Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell and natural-gas producer BKV Corp. ended flat Thursday, the day the two initial public offerings debuted. At the closing bell, BioAge's stock (BIOA) stood at $18.31 for a 1.7% gain over its IPO price. Earlier, the stock had been up as much as 30%.
BKV Corporation Announces Pricing of Initial Public Offering
WEB2 days ago · DENVER-- (BUSINESS WIRE)-- BKV Corporation (“BKV”) today announced the pricing of its initial public offering of 15,000,000 shares of its common stock at $18.00 per share. The underwriters will have a 30-day option to purchase an additional 2,250,000 shares from BKV at the initial public offering price, less underwriting discounts and ...
BKV Corporation (BKV) Stock Price, News, Quote & History
WEBDENVER, September 25, 2024--BKV Corporation ("BKV") today announced the pricing of its initial public offering of 15,000,000 shares of its common stock at $18.00 per share. The underwriters will have a 30-day option to purchase an additional 2,250,000 shares from BKV at the initial public offering price, less underwriting discounts and commissions.
Natgas producer BKV valued at $1.56 billion in NYSE debut
WEB1 day ago · By Vedant Vinayak Vichare and Pritam Biswas. (Reuters) -Shares of BKV rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas producer a market ...
IPOs debuting from BKV and BioAge - MarketWatch
WEB2 days ago · Texas-based Barnett Shale driller BKV Inc. priced below the estimated range, while obesity-drug developer BioAge Labs Inc. priced midrange ahead of their first day of trading on Thursday. As the ...
- Some results have been removed